Lockshin Curtis

CIK 00013835566 companiesMIAMI, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001383556

Recent Transactions

31 trades

Award
Phio Pharmaceuticals Corp.$PHIO
Common Stock, $.0001 par value
2025-09-11+16,200→ 18,555 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common Stock, $0.0001 par value
2024-09-11+2,000→ 2,000 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Options
2023-12-11+10,000→ 10,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common stock, $0.0001 par value
2023-02-17+1,500→ 3,197 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Options
2022-03-24+50,000→ 50,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common stock, $0.0001 par value
2022-02-15+10,000→ 20,366 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Options
2021-03-18+50,000→ 50,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common stock, $0.0001 par value
2021-03-01+10,000→ 10,366 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Options
2019-12-04+90,000→ 90,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common stock
2019-02-13+10,000→ 20,130 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common Stock
2018-08-01+10,000→ 10,130 total
Award
Phio Pharmaceuticals Corp.$PHIO
Stock option (right to buy)
2017-02-01+2,000→ 2,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Stock option (right to buy)
2016-02-10+16,666→ 16,666 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common stock warrant
2015-06-02+6,000→ 6,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Common stock, $0.0001 par value
2015-06-02$0.40/sh+12,000→ 13,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Overallotment purchase right
2015-06-02+6,000→ 6,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Stock option (right to buy)
2015-06-01+16,666→ 16,666 total
Purchase
Phio Pharmaceuticals Corp.$PHIO
Common stock, $0.0001 par value
2013-08-29$3.70/sh+1,000→ 1,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Stock Option (right to buy)
2013-04-18+1,000,000→ 1,000,000 total
Award
Phio Pharmaceuticals Corp.$PHIO
Stock Option (right to buy)
2013-04-18+1,000,000→ 1,000,000 total
Disposition to Issuer
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21−67,500→ 67,500 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21+45,651→ 113,151 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-08-28+67,500→ 135,000 total
Award
Sorrento Therapeutics, Inc.
Non-qualifed stock option
2012-07-20+15,000→ 15,000 total
Award
Sorrento Therapeutics, Inc.
Non-qualifed stock option
2012-02-06+100,000→ 100,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2011-05-10+67,500→ 67,500 total
Award
Sorrento Therapeutics, Inc.
Non-qualifed stock option
2011-04-15+2,500→ 92,500 total
Award
Sorrento Therapeutics, Inc.
Non-qualifed stock option
2010-11-29+35,000→ 90,000 total
Award
Sorrento Therapeutics, Inc.
Non-qualifed stock option
2010-02-05+15,000→ 55,000 total
Award
Winston Pharmaceuticals, Inc.
Common Stock Options
2009-09-25+27,500→ 27,500 total
Award
Sorrento Therapeutics, Inc.
Option to Purchase Common Stock
2009-09-21+40,000→ 40,000 total

Companies

Recent Filings

Address

4400 BISCAYNE BOULEVARD SUITE 950

MIAMI, FL, 33137

View on SEC.gov